Rick Fuller

864 total citations
8 papers, 654 citations indexed

About

Rick Fuller is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Rick Fuller has authored 8 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in Rick Fuller's work include Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (4 papers) and Respiratory and Cough-Related Research (3 papers). Rick Fuller is often cited by papers focused on Asthma and respiratory diseases (7 papers), Allergic Rhinitis and Sensitization (4 papers) and Respiratory and Cough-Related Research (3 papers). Rick Fuller collaborates with scholars based in United States, United Kingdom and Australia. Rick Fuller's co-authors include Elise Burmeister Getz, Malinda Longphre, Sally E. Wenzel, Darren Wilbraham, Dennis M. Fisher, Brian W. Becker, Daniel A. Burgard, Mary Joyce A. Dinglasan-Panlilio, Jeffry G. Weers and David Cipolla and has published in prestigious journals such as The Lancet, The Science of The Total Environment and Pharmacological Reviews.

In The Last Decade

Rick Fuller

8 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rick Fuller United States	5	446	268	225	140	80	8	654
Edmund Yung Hong Kong	16	462 1.0×	275 1.0×	115 0.5×	217 1.6×	66 0.8×	24	751
Soichiro Hozawa Japan	14	420 0.9×	354 1.3×	63 0.3×	59 0.4×	41 0.5×	56	596
Marianne A. van de Pol Netherlands	11	254 0.6×	163 0.6×	81 0.4×	53 0.4×	29 0.4×	18	452
Nicoletta De Marzo Italy	12	354 0.8×	317 1.2×	70 0.3×	66 0.5×	22 0.3×	24	834
Maria Ferrini United States	13	166 0.4×	67 0.3×	245 1.1×	39 0.3×	46 0.6×	17	500
K.Y. Murdock Canada	8	944 2.1×	737 2.8×	69 0.3×	403 2.9×	27 0.3×	8	1.1k
Kuan‐Wen Su Taiwan	13	177 0.4×	63 0.2×	42 0.2×	230 1.6×	127 1.6×	57	559
Karolien Bloemen Belgium	8	193 0.4×	130 0.5×	66 0.3×	75 0.5×	22 0.3×	8	407
Е. Тоскала Finland	12	385 0.9×	137 0.5×	24 0.1×	353 2.5×	145 1.8×	16	674
Astrid Crespo‐Lessmann Spain	12	242 0.5×	239 0.9×	67 0.3×	32 0.2×	50 0.6×	52	478

Countries citing papers authored by Rick Fuller

Since Specialization

Citations

This map shows the geographic impact of Rick Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Fuller more than expected).

Fields of papers citing papers by Rick Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Fuller. The network helps show where Rick Fuller may publish in the future.

Co-authorship network of co-authors of Rick Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Rick Fuller. A scholar is included among the top collaborators of Rick Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Fuller. Rick Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Anderson, Sandra D., Paul J. Atkins, Per Bäckman, et al.. (2022). Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews. 74(1). 48–118. 79 indexed citations

Longphre, Malinda, Elise Burmeister Getz, & Rick Fuller. (2017). Clinical Bioequivalence of OT329 SOLIS and ADVAIR DISKUS in Adults with Asthma. Annals of the American Thoracic Society. 14(2). 182–189. 4 indexed citations

Burgard, Daniel A., et al.. (2013). Potential trends in Attention Deficit Hyperactivity Disorder (ADHD) drug use on a college campus: Wastewater analysis of amphetamine and ritalinic acid. The Science of The Total Environment. 450-451. 242–249. 62 indexed citations

Getz, Elise Burmeister, et al.. (2012). Salmeterol pharmacokinetics following a 50-mcg dose by dry powder oral inhalation to healthy volunteers. 40. 1965. 1 indexed citations

Getz, Elise Burmeister, Dennis M. Fisher, & Rick Fuller. (2009). Human Pharmacokinetics/Pharmacodynamics of an Interleukin‐4 and Interleukin‐13 Dual Antagonist in Asthma. The Journal of Clinical Pharmacology. 49(9). 1025–1036. 42 indexed citations

Wenzel, Sally E., Darren Wilbraham, Rick Fuller, Elise Burmeister Getz, & Malinda Longphre. (2007). Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies. The Lancet. 370(9596). 1422–1431. 455 indexed citations

Birchall, Martin, Finbarr O’Connell, Alison Moorat, et al.. (1996). Topical Salmeterol Reduces Protein Content of Nasal Lavage Fluid in Response to Allergen and Histamine Challenge: Double-Blind Cross-over Placebo-Controlled Studies in Adults. American Journal of Rhinology. 10(4). 251–256. 4 indexed citations

Birchall, Martin, Ian Phillips, Rick Fuller, & N. B. Pride. (1993). Intranasal histamine challenge in normality and allergic rhinitis. Otolaryngology. 109(3). 450–456. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact